Leon Stankowski, PhD, is responsible for guiding research and development for new service offerings and providing guidance on all aspects of toxicology to help clients reach their goal of regulatory approval for new products.
He is responsible for evaluating and addressing adverse toxicology issues when they arise, as well as designing specialized protocols and mechanistic studies to resolve them. He regularly reviews study results and adverse outcomes for compounds being developed by various pharmaceutical and other companies and has has contributed to multiple publications.
Successfully Navigate Genetic Toxicology Testing Requirements
In this webinar, our experts share thoughts on testing strategies and approaches to address adverse genetic toxicology results. Watch to broaden your understanding of genetic toxicology testing so you can bring your drug to market safely, swiftly, and effectively.
Watch the Webinar